Excellent Long-term Clinical Response to Rivaroxaban in Livedoid Vasculopathy: A Retrospective Study

Actas Dermosifiliogr. 2023 Feb;114(2):183-185. doi: 10.1016/j.ad.2022.03.022. Epub 2022 Sep 14.

[Article in English, Spanish]

Authors

D Morgado-Carrasco¹, J Ibaceta¹, P Iranzo¹, X Bosch-Amate¹, J M Mascaró-Galy²

Affiliations

¹ Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España.
² Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España. Electronic address: [email protected].

PMID: 36115384
DOI: 10.1016/j.ad.2022.03.022

No abstract available

Publication types

Case Reports

MeSH terms

Humans
Livedo Reticularis* / drug therapy
Livedoid Vasculopathy*
Retrospective Studies
Rivaroxaban / therapeutic use

Substances

Rivaroxaban